BS, Loras College, Chemistry
MS, University of California at Berkeley, Bio-organic Chemistry
Ph.D., University of California at Davis
Dr. Joseph E. Plamondon is renowned in the industrial chemical community for his work on Toxic Substances Control Act (TSCA) matters, his presentations at professional events, his extensive writing on chemical regulatory matters, and his wealth of experience across the regulatory arena. Through numerous publications and presentations relating to TSCA and the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) for nearly 30 years, and publication of his unique book, "The Underlying Foundation of Science used in the Regulation of Industrial Chemicals," Dr. Plamondon has become the preeminent TSCA consulting scientist in the field. He has utilized his remarkable background to assist numerous companies in their TSCA compliance programs over the past 20 years.
Much of Dr. Plamondon's career has focused on the technical aspects of TSCA, especially chemistry, risk assessment, and toxicity to humans and the environment. The importance of these technical issues in the interpretation of statute requirements is apparent since implementing regulations are often written by chemists and other scientists in terms that can be understood only by those possessing a strong chemical background, normally a Ph.D.
For Bergeson & Campbell, P.C. (B&C®) clients, Dr. Plamondon is a tremendous resource for technical guidance on nomenclature issues, determination of TSCA Inventory status of manufactured and purchased chemicals, and preparations and submittal of Premanufacture Notifications (PMN) and exemption notices prior to manufacture of new chemical substances. He advises clients on development of supporting data. His writing has included publication of a paper on the U.S. Environment Protection Agency’s (EPA) Sustainable Futures program and the role that modeling can play in assessment of possible risk factors of a new chemical substance. Dr. Plamondon conducts TSCA audits and training programs for companies, and provides TSCA Section 8(e) Substantial Risk guidance for specific toxicological and exposure endpoints that may be reportable.